Trial Profile

Postprandial Blood Glucose Control With BioChaperone Combo and Insulin Lispro (Humalog) Mix 25 in People With Type 1 Diabetes Mellitus

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 06 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Insulin glargine/insulin lispro (Primary) ; Insulin neutral protamine lispro/insulin lispro
Indications Type 1 diabetes mellitus
Focus Pharmacodynamics
Sponsors Adocia

16 Sep 2016 Results assessing post-prandial glucose in type 1 diabetes patients, presented at the 52nd Annual Meeting of the European Association for the Study of Diabetes.
08 Sep 2016 According to an Adocia media release, data from this trial were presented at the 52nd European Association for the Study of Diabetes (EASD) Annual Meeting, 2016.
06 Jun 2016 Results will be presented at the American Diabetes Association 76th Scientific Sessions 2016, according to an Adocia media release.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com